{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:59:03Z","timestamp":1753891143246,"version":"3.41.2"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T00:00:00Z","timestamp":1638230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>Atrial fibrillation (AF) is an abnormal heart rhythm related to an increased risk of heart failure, dementia, and stroke. The distinction between valvular and non-valvular AF remains a debate. In this study, proteomics and metabolomics were integrated to describe the dysregulated metabolites and proteins of AF patients relative to sinus rhythm (SR) patients. Totally 47 up-regulated and 41 down-regulated proteins in valvular AF, and 59 up-regulated and 149 down-regulated proteins in non-valvular AF were recognized in comparison to SR patients. Moreover, 58 up-regulated and 49 significantly down-regulated metabolites in valvular AF, and 47 up-regulated and 122 down-regulated metabolites in persistent non-valvular AF patients were identified in comparison to SR patients. Based on analysis of differential levels of metabolites and proteins, 15 up-regulated and 22 down-regulated proteins, and 13 up-regulated and 122 down-regulated metabolites in persistent non-valvular AF were identified relative to valvular AF. KEGG pathway enrichment analysis showed the altered proteins and metabolites were significantly related to multiple metabolic pathways, such as Glycolysis\/Gluconeogenesis. Interestingly, the enrichment pathways related to non-valvular AF were obviously different from those in valvular AF. For example, valvular AF was significantly related to Glycolysis\/Gluconeogenesis, but non-valvular AF was more related to Citrate cycle (TCA cycle). Correlation analysis between the differentially expressed proteins and metabolites was also performed. Several hub proteins with metabolites were identified in valvular AF and non-valvular AF. For example, Taurine, D-Threitol, L-Rhamnose, and DL-lactate played crucial roles in valvular AF, while Glycerol-3-phosphate dehydrogenase, Inorganic pyrophosphatase 2, Hydroxymethylglutaryl-CoAlyase, and Deoxyuridine 5-triphosphate nucleotidohydrolase were crucial in non-valvular AF. Then two hub networks were recognized as potential biomarkers, which can effectively distinguish valvular AF and non-valvular persistent AF from SR samples, with areas under curve of 0.75 and 0.707, respectively. Hence, these metabolites and proteins can be used as potential clinical molecular markers to discriminate two types of AF from SR samples. In summary, this study provides novel insights to understanding the mechanisms of AF progression and identifying novel biomarkers for prognosis of non-valvular AF and valvular AF by using metabolomics and proteomics analyses.<\/jats:p>","DOI":"10.3389\/fgene.2021.789485","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T18:29:08Z","timestamp":1638383348000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Metabolomic and Proteomic Analyses of Persistent Valvular Atrial Fibrillation and Non-Valvular Atrial Fibrillation"],"prefix":"10.3389","volume":"12","author":[{"given":"Bo","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.cardiores.2005.04.016","article-title":"Matrix Metalloproteinases and Atrial Remodeling in Patients with Mitral Valve Disease and Atrial Fibrillation","volume":"67","author":"Anne","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.rec.2013.04.009","article-title":"Proteomics and Metabolomics for Mechanistic Insights and Biomarker Discovery in Cardiovascular Disease","volume":"66","author":"Barallobre-Barreiro","year":"2013","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11050306","article-title":"Glycolysis Metabolites and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Trial","volume":"11","author":"Becerra-Tom\u00e1s","year":"2021","journal-title":"Metabolites"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2020.07.006","article-title":"Hyperuricaemia and Gout in Cardiovascular, Metabolic and Kidney Disease","volume":"80","author":"Borghi","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/1096-9896(200011)192::3<280:aid-path748>3.0.co;2-l","article-title":"Proteomics: a New Approach to the Study of Disease","volume":"192","author":"Chambers","year":"2000","journal-title":"J. Pathol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41392-019-0093-2","article-title":"Role of the PPAR Pathway in Atrial Fibrillation Associated with Heart Valve Disease: Transcriptomics and Proteomics in Human Atrial Tissue","volume":"5","author":"Chen","year":"2020","journal-title":"Sig Transduct Target. Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ahj.2016.05.004","article-title":"A Comparison of the CHARGE-AF and the CHA2DS2-VASc Risk Scores for Prediction of Atrial Fibrillation in the Framingham Heart Study","volume":"178","author":"Christophersen","year":"2016","journal-title":"Am. Heart J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.acvd.2015.06.002","article-title":"How to Define Valvular Atrial Fibrillation?","volume":"108","author":"Fauchier","year":"2015","journal-title":"Arch. Cardiovasc. Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1111\/j.1471-4159.2009.06040.x","article-title":"Protection of Midbrain Dopaminergic Neurons by the End-Product of Purine Metabolism Uric Acid: Potentiation by Low-Level Depolarization","volume":"109","author":"Guerreiro","year":"2009","journal-title":"J. Neurochem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.bbrc.2019.06.055","article-title":"Regulating the Warburg Effect on Metabolic Stress and Myocardial Fibrosis Remodeling and Atrial Intracardiac Waveform Activity Induced by Atrial Fibrillation","volume":"516","author":"Hu","year":"2019","journal-title":"Biochem. Biophysical Res. Commun."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e0196709","DOI":"10.1371\/journal.pone.0196709","article-title":"Lipidomic Profiling Reveals Free Fatty Acid Alterations in Plasma from Patients with Atrial Fibrillation","volume":"13","author":"Jung","year":"2018","journal-title":"PLoS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jacc.2008.03.043","article-title":"Application of Metabolomics to Cardiovascular Biomarker and Pathway Discovery","volume":"52","author":"Lewis","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/14779072.2017.1355237","article-title":"Persistent Atrial Fibrillation vs Paroxysmal Atrial Fibrillation: Differences in Management","volume":"15","author":"Margulescu","year":"2017","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jacc.2007.09.055","article-title":"Combined Metabolomic and Proteomic Analysis of Human Atrial Fibrillation","volume":"51","author":"Mayr","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.57390","article-title":"Population-scale Proteome Variation in Human Induced Pluripotent Stem Cells","volume":"9","author":"Mirauta","year":"2020","journal-title":"Elife"},{"key":"B16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ahj.2021.01.012","article-title":"A Randomized Ablation-Based Atrial Fibrillation Rhythm Control versus Rate Control Trial in Patients with Heart Failure and High burden Atrial Fibrillation: The RAFT-AF Trial Rationale and Design","volume":"234","author":"Parkash","year":"2021","journal-title":"Am. Heart J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1005752","DOI":"10.1371\/journal.pcbi.1005752","article-title":"mixOmics: An R Package for 'omics Feature Selection and Multiple Data Integration","volume":"13","author":"Rohart","year":"2017","journal-title":"Plos Comput. Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2147\/VHRM.S10758","article-title":"The Pathology and Treatment of Cardiac Arrhythmias: Focus on Atrial Fibrillation","volume":"7","author":"Schmidt","year":"2011","journal-title":"Vasc. Health Risk Manag."},{"key":"B19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s00399-017-0551-x","article-title":"Proteomics and Transcriptomics in Atrial Fibrillation","volume":"29","author":"S\u00fchling","year":"2018","journal-title":"Herzschr Elektrophys"},{"key":"B20","doi-asserted-by":"publisher","first-page":"7650976","DOI":"10.1155\/2016\/7650976","article-title":"Circulating Glutamate and Taurine Levels Are Associated with the Generation of Reactive Oxygen Species in Paroxysmal Atrial Fibrillation","volume":"2016","author":"Takano","year":"2016","journal-title":"Dis. Markers"},{"key":"B21","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1253\/circj.cj-12-0057","article-title":"Uric Acid and Atrial Fibrillation","volume":"76","author":"Watanabe","year":"2012","journal-title":"Circ. J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1749-8090-8-34","article-title":"Intracellular Lactate Signaling cascade in Atrial Remodeling of Mitral Valvular Patients with Atrial Fibrillation","volume":"8","author":"Xu","year":"2013","journal-title":"J. Cardiothorac. Surg."},{"key":"B23","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/978-94-024-1079-2_64","article-title":"Taurine Prevents the Electrical Remodeling in Ach-CaCl2 Induced Atrial Fibrillation in Rats","author":"Yang","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s11306-019-1557-7","article-title":"Comprehensive Metabolomic and Proteomic Analyses Reveal Candidate Biomarkers and Related Metabolic Networks in Atrial Fibrillation","volume":"15","author":"Zhou","year":"2019","journal-title":"Metabolomics"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.789485\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T18:29:09Z","timestamp":1638383349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.789485\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,30]]},"references-count":24,"alternative-id":["10.3389\/fgene.2021.789485"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2021.789485","relation":{},"ISSN":["1664-8021"],"issn-type":[{"type":"electronic","value":"1664-8021"}],"subject":[],"published":{"date-parts":[[2021,11,30]]},"article-number":"789485"}}